|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 3 of 27 found articles
| Title: |
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial |
| Author: |
Zimmer, Lisa Livingstone, Elisabeth Hassel, Jessica C Fluck, Michael Eigentler, Thomas Loquai, Carmen Haferkamp, Sebastian Gutzmer, Ralf Meier, Friedegund Mohr, Peter Hauschild, Axel Schilling, Bastian Menzer, Christian Kieker, Felix Dippel, Edgar Rösch, Alexander Simon, Jan-Christoph Conrad, Beate Körner, Silvia Windemuth-Kieselbach, Christine Schwarz, Leonora Garbe, Claus Becker, Jürgen C Schadendorf, Dirk |
| Appeared in: |
Lancet |
| Paging: | Volume 395 () nr. 10236 pages 1558-1568 |
| Year: |
2020 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 3 of 27 found articles
| << previous | next >> |